<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "apixaban tab>
<dose><value>2.5</value>
<value>5</value>
<value>10</value>
</dose><route><value>PO</value>
</route><form><value>tab</value>
</form><drugname><value>apixaban tab</value>
</drugname><strength><value>2.5 mg</value>
<value>5 mg</value>
</strength><frequency><value>BID</value>
</frequency><instruction><value></value>
<value>Administer for 7 days, followed by 5 mg BID.</value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
</units><additionalnotes><value>VTE prevention post-elective hip and knee replacement surgery.</value>
<value>Stroke prevention in patients with Atrial Fibrillation.</value>
<value>Stroke prevention in patients with Atrial Fibrillation, if meeting 2 of body weight 60kg or less, age of 80 years or greater or serum creatinine is 133 umol or greater.</value>
<value>DVT/PE treatment</value>
</additionalnotes><population><value></value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=4921</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6241</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions, Usage guidelines.</value>
</ahsformularystatus><ahfsname><value>Antithrombotic Agents, Anticoagulants</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>